AKT1 and breast carcinoma: To confirm that butein reduction of ROS production affected cell viability by inhibiting AKT phosphorylation, butein-sensitive and -resistant breast cancer cells were treated with NAC or homobutein (a structural similarity between homobutein and butein = 0.914) [40].